Catheter Precision, Inc. (NYSEAMERICAN:VTAK) Short Interest Up 156.0% in March

Catheter Precision, Inc. (NYSEAMERICAN:VTAK) was the target of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 29,700 shares, a growth of 156.0% from the February 29th total of 11,600 shares. Based on an average daily trading volume, of 53,100 shares, the days-to-cover ratio is currently 0.6 days. Currently, 0.5% of the company’s stock are sold short.

Catheter Precision Trading Up 2.0 %

NYSEAMERICAN:VTAK traded up $0.01 during trading hours on Thursday, reaching $0.50. 9,187 shares of the company traded hands, compared to its average volume of 53,133. Catheter Precision has a 1 year low of $0.34 and a 1 year high of $1.70.

About Catheter Precision

Catheter Precision, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.